The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: A narrative review

Diabetic Medicine

Volumn 29, Issue 3, 2012, Pages 293-302

  Barendse, S ^a   Singh, H ^b   Frier, B M ^c   Speight, J ^a,d,e  

^a AHP Research   (United Kingdom)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d THE AUSTRALIAN CENTRE FOR BEHAVIOURAL RESEARCH IN DIABETES   (Australia)

^e DEAKIN UNIVERSITY   (Australia)

Author keywords

Health status; Hypoglycaemia; Patient reported outcomes; Quality of life; Type2 diabetes

Indexed keywords

GLUCOSE;

ANXIETY; AWARENESS; DAILY LIFE ACTIVITY; DEPRESSION; DIABETIC PATIENT; DIETARY INTAKE; DISEASE ASSOCIATION; DRIVING ABILITY; EMOTION; FAMILY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN RELATION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; REVIEW; RISK FACTOR; SELF REPORT; SOCIAL LIFE; SYMPTOM; TREATMENT OUTCOME; WORK CAPACITY;

ACTIVITIES OF DAILY LIVING; ANXIETY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; QUALITY OF LIFE; SELF CARE; TREATMENT OUTCOME;

EID: 84857297404     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03416.x     Document Type: Review

References (93)

1. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948-2961.
2. Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008; 24: 87-92.
3. Frier BM. Living with hypoglycaemia. In: Frier BM, ed. Hypoglycaemia in Clinical Diabetes. 2nd edn. Chichester: John Wiley and Sons, 2007.
4. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002; 45: 937-948.
5. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. J Diabetes Complications 2006; 20: 402-408.
6. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Frier BM, ed. Hypoglycaemia in Clinical Diabetes. 2nd edn. Chichester: John Wiley and Sons, 2007: 49-81.
7. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003; 20: 1016-1021.
8. Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes. J Diabetes Complications 2005; 19: 10-17.
9. Guisasola FA, Povedano ST, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes, Obes Metab 2008; 10: 25-32.
10. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147.
11. Cryer PE. Hypoglycemia in Diabetes. Pathophysiology, Prevalence and Prevention. Alexandria, VA: American Diabetes Association, 2009.
12. Reach G. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther 2008; 10: 69-80.
13. Nielsen JK, Djurhuus CB, Gravholt CH, Carus AC, Granild-Jensen J, Orskov H et al. Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex. Diabetes 2005; 54: 1635-1639.
14. Cryer PE. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
15. Swinnen SG, Mullins P, Miller M, Hoekstra JB, Holleman F. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia 2009; 52: 38-41.
16. Renard E. Monitoring glycemic control: the importance of self-monitoring of blood glucose. Am J Med 2005; 118: 12S-19S.
17. Frier BM. Defining hypoglycaemia: what level has clinical relevance? Diabetologia 2009; 52: 31-34.
18. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 Type 1 diabetic patients. Diabet Med 1991; 8: 217-222.
19. Snoek FJ. Barriers to good glycaemic control: the patient's perspective. Int J Obes Relat Metab Disord 2000; 24: S12-20.
20. Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Groenier KH, Meyboom-de Jong B, Bilo HJG. Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med 2005; 63: 215-221.
21. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993; 36: 771-777.
22. Levy AR, Christensen TL, Johnson JA. Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the UK. Health Qual Life Outcomes 2008; 6: 73.
23. Matza LS, Boye KS, Yurgin N. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes 2007; 5: 47.
24. American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes 1993; 42: 1555-1558.
25. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-1483.
26. Marrett E, Stargardt T, Mavros P, Alexander CM. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. Diabetes Obes Metab 2009; 11: 1138-1144.
27. Bastyr EJ 3rd, Huang Y, Brunelle RL, Vignati L, Cox DJ, Kotsanos JG. Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro. Diabetes Obes Metab 2000; 2: 39-46.
28. Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-1483.
29. Marouf E, Sinclair AJ. Use of short-acting insulin aspart in managing older people with diabetes. Clin Interv Aging 2009; 4: 187-190.
30. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26: 1153-1157.
31. Woodward A, Weston P, Casson IF, Gill GV. Nocturnal hypoglycaemia in type 1 diabetes-frequency and predictive factors. QJM 2009; 102: 603-607.
32. Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality-of-life measurement in adults with diabetes. Diabet Med 2009; 26: 315-327.
33. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. J Am Med Assoc 1994; 272: 619-626.
34. Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev 2004; 20: S13-18.
35. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004; 26: 565-578.
36. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-621.
37. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91.
38. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007; 68: 10-15.
39. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673-2679.
40. Shiu AT, Wong RY. Fear of hypoglycaemia among insulin-treated Hong Kong Chinese patients: implications for diabetes patient education. Patient Educ Couns 2000; 41: 251-261.
41. Hepburn DA. Symptoms of hypoglycaemia. In: Frier BM, Fisher M, eds. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. London: Edward Arnold, 1993: 93-103.
42. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance. In: Frier BM, ed. Hypoglycaemia in Clinical Diabetes. Chichester: John Wiley and Sons, 2007: 25-48.
43. Brierley EJ, Broughton DL, James OFW, Alberti KGMM. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM 1995; 88: 439-445.
44. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135-141.
45. Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM. Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin. Diabet Med 1998; 15: 398-401.
46. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance and emotions. In: Frier BM, Fisher M, eds. Hypoglycaemia in Clinical Diabetes. 2nd edn. Chichester: John Wiley and Sons, 2007: 25-48.
47. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001; 18: 690-705.
48. Cryer PE. Hypoglycemia in Diabetes: Pathophysiology, Prevalence and Prevention. Alexandria, VA: American Diabetes Association, 2009.
49. Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care 1995; 18: 523-528.
50. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care 2001; 24: 637-642.
51. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO et al. Outcomes of pregnancy in insulin-dependent diabetic women: results of a five-year population cohort study. Br Med J 1997; 315: 275-278.
52. Gold DAE, Pearson DDWM. Hypoglycaemia in pregnancy. In: Frier BM, ed. Hypoglycaemia in Clinical Diabetes. 2nd edn. Chichester: John Wiley and Sons, 2007: 217-237.
53. Ritholz M. Working with challenging patients in diabetes treatment. In: Weinger K, Carver CA, eds. Contemporary Diabetes: Educating your Patient with Diabetes. 1st edn. New York: Humana Press, 2009: 197-212.
54. Asimakopoulou KG, Fox C, Spimpolo J, Marsh S, Skinner TC. The impact of different time frames of risk communication on Type 2 diabetes patients' understanding and memory for risk of coronary heart disease and stroke. Diabet Med 2008; 25: 811-817.
55. Asimakopoulou KG, Skinner TC, Spimpolo J, Marsh S, Fox C. Unrealistic pessimism about risk of coronary heart disease and stroke in patients with type 2 diabetes. Patient Educ Couns 2008; 71: 95-101.
56. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001; 161: 1653-1659.
57. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163-183.
58. Ter Braak EWMT, De Valk HW, De La Bije YF, Van Der Laak MF, Van Haeften TW, Erkelens DW. Response to training in blood glucose awareness is related to absence of previous hypoglycomic coma. Diabetes Care 2000; 23: 1199-1200.
59. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in Type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. J Am Med Assoc 2001; 286: 1218-1227.
60. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29: 1433-1438.
61. Hayes C. Case study: Exercise-related hypoglycemia in type 2 diabetes treated with oral glucose-lowering medications. Clin Diabetes 2007; 25: 150-151.
62. Reiter J, Wexler ID, Shehadeh N, Tzur A, Zangen D. Type 1 diabetes and prolonged fasting. Diabet Med 2007; 24: 436-439.
63. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA et al. Recommendations for management of diabetes during Ramadan. Diabetes Care 2005; 28: 2305-2311.
64. Perros P, Deary IJ. Long-term effects of hypoglycemia on cognitive function and the brain in diabetes. In: Frier BM, ed. Hypoglycaemia in Clinical Diabetes. 2nd edn. Chichester: John Wiley and Sons, 2007.
65. Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005; 7: 493-503.
66. Adolfsson R, Bucht G, Lithner F, Winblad B. Hypoglycemia in Alzheimer's disease. Acta Med Scand 1980; 208: 387-388.
67. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. J Am Med Assoc 2009; 301: 1565-1572.
68. Graveling AJ, Frier BM. Hypoglycaemia: an overview. Prim Care Diabetes 2009; 3: 131-139.
69. Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005; 7: 493-503.
70. Strachan MWJ, Reynolds RM, Frier BM, Mitchell RJ, Price JF. The relationship between type 2 diabetes and dementia. Br Med Bull 2008; 88: 131-146.
71. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ. A 4-year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010; 53: 58-65.
72. Wright RJ, Frier BM. Vascular disease and diabetes: Is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008; 24: 353-363.
73. Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008; 10: S16-24.
74. Jermendy G, Erdesz D, Nagy L, Yin D, Phatak H, Karve S et al. Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. Health Qual Life Outcomes 2008; 6: 88.
75. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S et al. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2009; 19: 45-53.
76. King P, Kong MF, Parkin H, Macdonald IA, Tattersall RB. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998; 21: 341-345.
77. Matyka KA, Wigg L, Pramming S, Stores G, Dunger DB. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Arch Dis Child 1999; 81: 138-142.
78. Chau DL, Edelman SV, Chandran M. Osteoporosis and diabetes. Curr Diab Rep 2003; 3: 37-42.
79. Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008; 24: 87-92.
80. Leiter LA, Yale JF, Chiasson JL, Harris SB, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005; 29: 186-192.
81. Polonsky WH. Time for a 'diabetes vacation'? Diabetes Forecast 2005; 58: 11.
82. Gold AE, Deary IJ, Frier BM. Hypoglycaemia and non-cognitive aspects of psychological function in insulin-dependent (Type 1) diabetes mellitus (IDDM). Diabet Med 1997; 14: 111-118.
83. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 2000; 23: 305-312.
84. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, co-morbidity and risk factors. Diabet Med 2005; 22: 293-300.
85. Monahan PO, Lane KA, Hayes RP, McHorney CA, Marrero DG. Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes: the PAM-D. Qual Life Res 2009; 18: 941-952.
86. Ishii H, Furuya M, Iburi T, Yamagami K, Ishibashi R, Tsujii S. Insulin therapy related QOL at night (ITR-QOLN). J Japan Diabetes Soc 2008; 51: 593-600.
87. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002; 18: S64-S69.
88. Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev 2002; 18: S64-69.
89. Ritholz MD, Jacobson AM. Living with hypoglycemia. J Gen Intern Med 1998; 13: 799-804.
90. Stork AD, van Haeften TW, Veneman TF. The decision not to drive during hypoglycemia in patients with type 1 and type 2 diabetes according to hypoglycemia awareness. Diabetes Care 2007; 30: 2822-2826.
91. Forrest KYZ, Bunker CH, Songer TJ, Coben JH, Cauley JA. Driving patterns and medical conditions in older women. J Am Geriatr Soc 1997; 45: 1214-1218.
92. Leckie AM, Graham MK, Grant JB, Ritchie PJ, Frier BM. Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care 2005; 28: 1333-1338.
93. Matthews DR, Matthews PC. Banting Memorial Lecture 2010. Type 2 diabetes as an 'infectious' disease: is this the Black Death of the 21st century? Diabet Med 2011; 28: 2-9.